Belgian PM De Wever defends pharma sector amid GSK restructuring, cites US-China pressure

Belgian PM Bart De Wever stated the Belgian pharmaceutical sector must be protected, attributing GSK's restructuring to US and Chinese policies rather than domestic competitiveness. He cautioned against copying others' mistakes, implying a need for strategic autonomy. The statement signals potential policy shifts in Belgium's industrial strategy, though concrete measures remain unspecified.